Skip to main content
SpringerLink
Log in

Adenoviral Transfer of mda-7 Leads to BAX Up-regulation and Apoptosis in Mesothelioma Cells, and is Abrogated by Over-expression of BCL-XL

  • Original Articles
  • Published:
Molecular Medicine Aims and scope Submit manuscript

Abstract

Background

Malignant pleural mesothelioma (MPM) is unresponsive to conventional therapies. Forced expression of the novel tumor suppressor mda-7 gene in other cell types has resulted in decreased growth and apoptosis. We evaluated cell growth, apoptosis and tumor suppressor characteristics following forced expression of this gene in mesothelioma cell lines.

Methods

MDA-7 expression in human MPM cells at baseline, following pharmacologic differentiation and viral mda-7 transduction (Ad-mda7) were evaluated with Western blot. Cell viability was evaluated with a colorimetric (XTT) assay, and apoptosis with subG1 FACS and Hoescht. Caspase-3 expression was evaluated by functional assay. These parameters were also evaluated in a stable bcl-xl hyper-expressing MPM cell line. Bax mRNA levels were evaluated with realtime PCR.

Results

No baseline or differentiated MPM MDA7 expression was found, but was noted following Ad-mda7 exposure. More than 50% of MPM cells were killed at 5 days following Ad-mda7 exposure (p < 0.001). Apoptosis was accompanied by caspase-3 cleavage and increased BAX expression at both the protein (translational) and mRNA (transcriptional) level. These findings were reduced in a bcl-xl hyper-expressing cell line (P < 0.01).

Conclusions

Although mda-7 does not appear to be a MPM suppressor gene, adenoviral-mediated expression in cell lines induces apoptotic cellular death related to BAX upregulation and caspase cleavage. This is supported by abrogation of effect in a bcl-xl hyper-expressing cell line.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Ong ST, Vogelzang NJ. (1996) Chemotherapy in malignant pleural mesothelioma. A review. J. Clin. Oncol. 14(3): 1007–1017.

    Article  CAS  PubMed  Google Scholar 

  2. Sahmoud T, Postmus PE, van Pottelsberghe C, et al. (1997) Etoposide in malignant pleural mesothelioma: two phase II trails of the EORTC Lung Cancer cooperative Group. Eur. J. Cancer. 33(13): 2211–2215.

    Article  CAS  PubMed  Google Scholar 

  3. Antman KH. (1989) Natural history and staging of malignant mesothelioma. Chest. 96(1 Suppl): 93S–95S.

    Article  CAS  PubMed  Google Scholar 

  4. Frizelle SP, Rubins JB, Zhou JX, et al. (2000) Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus. Cancer Gene Ther. 7(11): 1421–1425.

    Article  CAS  PubMed  Google Scholar 

  5. Smythe WR, Hwang HC, Amin KM, et al. (1994) Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res. 54(8): 2055–2059.

    PubMed  CAS  Google Scholar 

  6. Smythe WR, Hwang HC, Elshami AA, et al. (1995) Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene. Ann. Surg. 222(1): 78–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Pass HI, Robinson BW, Testa JR, Carbone M. (1999) Emerging translational therapies for mesothelioma. Chest. 116(6 Suppl): 455S–460S.

    Article  CAS  PubMed  Google Scholar 

  8. Sterman DH, Treat J, Litzky LA, et al. (1998) Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum. Gene Ther. 9(7): 1083–1092.

    Article  CAS  PubMed  Google Scholar 

  9. Taguchi T, Jhanwar SC, Siegfried JM, et al. (1993) Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res. 53(18): 4349–4355.

    PubMed  CAS  Google Scholar 

  10. Mor O, Yaron P, Huszar M, et al. (1997) Absence of p53 mutations in malignant mesotheliomas. Am. J. Respir. Cell Mol. Biol. 16(1): 9–13.

    Article  CAS  PubMed  Google Scholar 

  11. Nishiyama Y, Suwa H, Okamoto K, (1995) Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn. J. Cancer Res. 86(12): 1150–1158.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Soini Y, Kinnula V, Kaarteenaho-Wiik R, et al. (1999) Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma. Clin. Cancer Res. 5(11): 3508–3515.

    PubMed  CAS  Google Scholar 

  13. Narasimhan SR, Yang L, Gerwin BI, Broaddus VC. (1998) Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax. Am. J. Physiol. 275(1 Pt 1): L165–L171.

    PubMed  CAS  Google Scholar 

  14. Jiang H, Lin J, Su Z-Z, et al. (1995) Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene. 11: 2477–2486.

    PubMed  CAS  Google Scholar 

  15. Madireddi MT, Dent P, Fisher PB. (2000) Regulation of mda-7 gene expression during human melanoma differentiation. Oncogene. 19(10): 1362–1368.

    Article  CAS  PubMed  Google Scholar 

  16. Ekmekcioglu S, Ellerhorst J, Mhashilkar AM, et al. (2001) Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Intl. J. Cancer. 94(1): 54–59.

    Article  CAS  Google Scholar 

  17. Jiang H, Su Z-Z, Lin JJ, et al. (1996) The Melanoma Differentiation Associated Gene MDA-7 Suppresses Cancer Cell Growth. Proc. Natl. Acad. Sci. USA. 93: 9160–9165.

    Article  CAS  PubMed  Google Scholar 

  18. Su ZZ, Madireddi MT, Lin JJ, et al. (1998) The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Natl. Acad. Sci. USA. 95(24): 14400–14405.

    Article  CAS  PubMed  Google Scholar 

  19. Saeki T, Mhashilkar A, Chada S, et al. (2000) Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer in vitro. Gene Ther. 7: 2051–2057.

    Article  CAS  PubMed  Google Scholar 

  20. Madireddi MT, Su ZZ, Young CS, et al. (2000) Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy. Adv. Exp. Med. Biol. 465: 239–261.

    Article  CAS  PubMed  Google Scholar 

  21. Mhashilkar AM, Schrock RD, Hindi M, et al. (2001) Melanoma differentiation associated gene (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol. Med. 7(4): 271–282.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Cao XX, Mohiuddin I, Ece F, et al. (2001) Histone deacetylase inhibitor down-regulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma. Am. J. Respir. Cell Mol. Biol. 25(5): 562–568.

    Article  CAS  PubMed  Google Scholar 

  23. Korsmeyer SJ. (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59(7 Suppl): 1693s–1700s.

    PubMed  CAS  Google Scholar 

  24. Nasreen N, Mohammed KA, Dowling PA, et al. (2000) Talc induces apoptosis in human malignant mesothelioma cells in vitro. Am. J. Respir. Crit. Care Med. 161(2 Pt 1): 595–600.

    Article  CAS  PubMed  Google Scholar 

  25. Rubins JB, Greatens T, Kratzke RA, et al. (1998) Lovastatin induces apoptosis in malignant mesothelioma cells. Am. J. Respir. Crit. Care Med. 157(5 Pt 1): 1616–1622.

    Article  CAS  PubMed  Google Scholar 

  26. Broaddus VC, Yang L, Scavo LM, et al. (1996) Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J. Clin. Invest. 98(9): 2050–2059.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Marklund L, Henriksson R, Grankvist K. (2000) Amphotericin B-induced apoptosis and cytotoxicity is prevented by the Na+, K+, 2Cl(-)-cotransport blocker bumetanide. Life Sci. 66(23): L319–L324.

    Article  Google Scholar 

  28. Su Z, Madireddi M, Lin J, et al. (1998) The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Natl. Acad. Sci. USA. 95: 14400–14405.

    Article  CAS  PubMed  Google Scholar 

  29. Mohiuddin I, Cao X, Fang B, et al. (2001) Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma. Cancer Gene Ther. 8: 547–554.

    Article  CAS  PubMed  Google Scholar 

  30. Shimizu S, Shinohara Y, Tsujimoto Y. (2000) Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator. Oncogene. 19(38): 4309–4318.

    Article  CAS  PubMed  Google Scholar 

  31. Kim CN, Wang X, Huang Y, et al. (1997) Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57(15): 3115–3120.

    PubMed  CAS  Google Scholar 

  32. Gottlieb E, Vander Heiden MG, Thompson CB. (2000) Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol. Cell Biol. 20(15): 5680–5689.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 109, Houston, Texas, 77030, USA

    Xiaobo X. Cao, Imran Mohuiddin, Mustafa K. Ozvaran, Steven D. Miller, Jonathon C. Daniel & W. Roy Smythe

  2. Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, USA

    David J. McConkey

  3. Introgen Therapeutics, Inc., Houston, TX, USA

    Sunil Chada & Abner M. Mhashilkar

Authors
  1. Xiaobo X. Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Imran Mohuiddin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sunil Chada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Abner M. Mhashilkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mustafa K. Ozvaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David J. McConkey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Steven D. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jonathon C. Daniel
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. Roy Smythe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Roy Smythe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cao, X.X., Mohuiddin, I., Chada, S. et al. Adenoviral Transfer of mda-7 Leads to BAX Up-regulation and Apoptosis in Mesothelioma Cells, and is Abrogated by Over-expression of BCL-XL. Mol Med 8, 869–876 (2002). https://doi.org/10.1007/BF03402093

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03402093

Keywords

Search

Navigation